Truvestments Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1K | Buy |
42
+26
| +163% | +$13.7K | ﹤0.01% | 519 |
|
|
2025
Q1 | $10.1K | Sell |
16
-26
| -62% | -$16.5K | ﹤0.01% | 654 |
|
|
2024
Q4 | $29.9K | Buy |
42
+5
| +14% | +$3.56K | 0.01% | 446 |
|
|
2024
Q3 | $38.9K | Buy |
+37
| New | +$38.9K | 0.01% | 392 |
|
|
2024
Q2 | – | Sell |
-8
| Closed | -$7.7K | – | 578 |
|
|
2024
Q1 | $7.7K | Hold |
8
| – | – | ﹤0.01% | 515 |
|
|
2023
Q4 | $7.03K | Hold |
8
| – | – | ﹤0.01% | 552 |
|
|
2023
Q3 | $6.58K | Hold |
8
| – | – | ﹤0.01% | 483 |
|
|
2023
Q2 | $5.75K | Hold |
8
| – | – | ﹤0.01% | 513 |
|
|
2023
Q1 | $6.57K | Buy |
8
+5
| +167% | +$4.11K | ﹤0.01% | 476 |
|
|
2022
Q4 | $2.16K | Hold |
3
| – | – | ﹤0.01% | 713 |
|
|
2022
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 567 |
|
|
2022
Q2 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 573 |
|